Incivek

handshake

Pharma

Chasing a payday, new drugmakers favor solo launches: report

To partner or not to partner on a new drug launch? Of all the decisions emerging biopharma companies have to make, that's among the most important.

Eric Sagonowsky Apr 17, 2017 11:22am

Harvoni

Gilead's hep C sales will 'erode massively' as market wanes: Analyst

Sep 27, 2016 12:08pm